LA JOLLA, Calif., June 7 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at the 6th Annual Needham & Company, LLC Biotechnology and Medical Technology Conference in New York on Thursday, June 14th at 1:30 p.m., eastern.
A webcast of Dr. Kurtz's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.
About TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel product candidates and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain, and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer's disease. TorreyPines' common stock is traded on The Nasdaq Global Market under the symbol "TPTX." For detailed company information, including copies of this and other press releases, please visit TorreyPines' website at http://www.torreypinestherapeutics.com.
Company Contact: Craig Johnson TorreyPines Therapeutics, Inc. 858-623-5665, x158 cjohnson@torreypinestherapeutics.com Media Contact: Patricia Garrison Rx Communications 917-322-2567 pgarrison@RxIR.com Investor Contact: Rhonda Chiger Rx Communications 917-322-2569 rchiger@RxIR.com
TorreyPines Therapeutics, Inc.CONTACT: Craig Johnson of TorreyPines Therapeutics, Inc., +1-858-623-5665,ext. 158; or Media, Patricia Garrison, +1-917-322-2567, pgarrison@RxIR.com,or Investors, Rhonda Chiger, +1-917-322-2569, rchiger@RxIR.com, both of RxCommunications, for TorreyPines Therapeutics, Inc.
Web site: http://www.torreypinestherapeutics.com/
